Valuation (29%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.01 | 6.65 |
PEG Ratio (TTM) | 0.00 | -0.81 |
P/S Ratio (TTM) | 6.85 | 0.69 |
P/B Ratio (TTM) | 0.80 | 1.12 |
P/FCF Ratio (TTM) | -60.75 | 13.15 |
Price to 5YR AVG Earnings Ratio | N/A | 6.81 |
Price to 5YR AVG FCF Ratio | N/A | 7.31 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.61% | 5.26% |
ROE (TTM) | -8.78% | 8.23% |
Net Profit Margin (TTM) | -13.06% | 4.97% |
ROIC 5YR AVG | N/A | 18.59% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -722.23% | 13.85% | N/A |
Revenue | -15.50% | 36.02% | N/A |
Net Income | -744.56% | 13.42% | N/A |
Cash Flow | 7.31% | 38.18% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.44 | 2.39 |
Quick Ratio (TTM) | 1.16 | 1.36 |
D/E Ratio (TTM) | 0.50 | 0.34 |
Interest Coverage (TTM) | N/A | 26.62 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 5.70 | 3.33 |
LTL to 5YR AVG FCF | N/A | 2.87 |
Shares Outstanding Growth 5YR AVG | N/A | -3.67% |